Hesperidin modulates dextran sulfate sodium-induced ulcerative colitis in rats: Targeting sphingosine kinase-1- sphingosine 1 phosphate signaling pathway, mitochondrial biogenesis, inflammation, and apoptosis

Journal of Biochemical and Molecular Toxicology
Noha M ShafikAbla M Ebeid

Abstract

Ulcerative colitis (UC) is a chronic gastrointestinal disorder interfering with life quality. A total of 60 male Wistar rats were divided into four equal groups: Control (group I), hesperidin only (group II), UC untreated (group III), and UC treated with hesperidin (group IV). Hesperidin had modulatory effects on UC pathogenesis, which might be through alleviating colonic sphingosine phosphate phosphatase 2 messenger RNA expression and sphingosine kinase-1 levels, thus suppressing the subsequent downstream inflammatory and apoptotic cascades represented by decreased macrophage inflammatory protein-1α and enhancement of B-cell lymphoma 2 immunohistochemistry expression. Also, it improved mitochondrial biogenesis by increasing the peroxisome proliferator-activated receptor-gamma-coactivator 1-α level. It successfully restored redox potential as evidenced by marked alleviations of the nitric oxide and peroxynitrite levels, increasing total antioxidant capacity, and activating the superoxide dismutase enzyme. Also, hesperidin alleviated the UC disease activity index and improved the histopathological picture. These findings may offer a new therapeutic strategy for UC treatment.

References

Nov 1, 1992·Archives of Biochemistry and Biophysics·J S BeckmanM Tsai
Jun 22, 2000·Proceedings of the National Academy of Sciences of the United States of America·S M MandalaS Spiegel
Aug 9, 2002·The New England Journal of Medicine·Daniel K Podolsky
May 15, 2003·The Journal of Biological Chemistry·Kiyoshi Itagaki, Carl J Hauser
Apr 2, 2005·The Biochemical Journal·Yury J SigalAndrew J Morris
Jul 30, 2005·World Journal of Gastroenterology : WJG·Xi-Ming XuHong-Gang Yu
Aug 25, 2005·The Journal of Biological Chemistry·Michael MaceykaSarah Spiegel
Jan 26, 2006·Basic & Clinical Pharmacology & Toxicology·Somia BashirT D Dogra
Aug 19, 2006·IUBMB Life·Tamara M Leclercq, Stuart M Pitson
Feb 20, 2007·Diseases of the Colon and Rectum·Alexander C von RoonParis P Tekkis
May 15, 2007·Lancet·Daniel C Baumgart, Simon R Carding
Sep 26, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Ashley J SniderLina M Obeid
Apr 24, 2009·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Lei XuYong-qiang Zhou
Jul 9, 2014·Arquivos De Gastroenterologia·Luiz Gustavo de OliveiraJair Adriano Kopke de Aguiar
Jul 23, 2014·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gowrikumar SaiprasadGanapasam Sudhandiran
Oct 30, 2016·Critical Reviews in Food Science and Nutrition·Chaoyun Li, Hermann Schluesener
Dec 17, 2015·World Journal of Gastroenterology : WJG·Germaine D AgollahSunkuk Kwon
Mar 13, 2016·The Journal of Biological Chemistry·Kellie E CunninghamKevin P Mollen
Apr 10, 2016·The Journal of Biological Chemistry·Yoshimitsu TaguchiRichard L Proia
May 2, 2018·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Dongyu LiuLi Cao

❮ Previous
Next ❯

Citations

Dec 17, 2019·Current Pharmaceutical Design·Fan CaoHai-Feng Pan
Jan 17, 2020·International Journal of Molecular Sciences·Sonia ShastriRajaraman Eri
Dec 30, 2021·Journal of Biochemical and Molecular Toxicology·Shivani SinglaGopabandhu Jena

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.